Botulinum toxin in the treatment of tics

被引:103
|
作者
Kwak, CH
Hanna, PH
Jankovic, J
机构
[1] Baylor Coll Med, Parkinsons Dis Ctr, Dept Neurol, Houston, TX 77030 USA
[2] Baylor Coll Med, Movement Disorders Clin, Dept Neurol, Houston, TX 77030 USA
[3] JFK Med Ctr, New Jersey Neurosci Inst, Edison, NJ USA
关键词
D O I
10.1001/archneur.57.8.1190
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To evaluate the safety and efficacy of botulinum toxin A (BTX) injections in the treatment of ties in patients with Tourette syndrome (TS). Background: BTX is an effective treatment for an increasing number of conditions characterized by abnormal muscle contractions. BTX may improve not only the motor component of ties, but also premonitory sensations that precede ties. Methods: Thirty-five patients (30 male, 5 female) were treated with BTS in the sites of their most problematic ties. Response to BTX was based on a 0 to 4 clinical rating scale (0, no improvement, to 4, marked improvement in both severity and function). Questionnaires were administered to evaluate patients' impressions of overall efficacy and degree of benefit with premonitory sensations. Results: Mean duration of ties prior to initial injection was 15.3 years (range, 1-62 years) and mean duration of follow-up was 21.2 months (range, 1.5-84 months). The mean peak effect response in 35 patients treated in 115 sessions was 2.8 (range, 0-4); the mean duration of benefit was 14.4 weeks (maximum, 45 weeks), and the mean latency to onset of benefit was 3.8 days (maximum, 10 days). Twenty-one (84%) of 25 patients with premonitory sensations derived marked relief of these symptoms (mean benefit, 70.6%). Total mean dose was 502.1 U (range, 15-3550 U); mean number of visits, 3.3 (range, 1-16); and mean dose per visit, 119.9 U (range, 15-273 U). Sites of injections were as follows: cervical or upper thoracic area (17), upper face (14), lower face (7), vocal cords (dr), upper back and/or shoulder (3), scalp (1), forearm (1), leg (1) and rectus abdominis (1). Complications included neck weakness (4), dysphagia (2), ptosis (2), nausea (1), hypophonia (1), fatigue (1), and generalized weakness (1), which were all mild and transient. Conclusions: Botulinum toxin A injections are an effective and well-tolerated treatment of ties. In addition to improving the motor component of ties, BTX also provides relief of premonitory sensations.
引用
收藏
页码:1190 / 1193
页数:4
相关论文
共 50 条
  • [31] ANTITOXINS AND BOTULINUM TOXIN TREATMENT
    HAMBLETON, P
    COHEN, HE
    PALMER, BJ
    MELLING, J
    BRITISH MEDICAL JOURNAL, 1992, 304 (6832): : 959 - 960
  • [32] Botulinum toxin in the treatment of achalasia
    De Looze, DA
    EUROPEAN JOURNAL OF NEUROLOGY, 1997, 4 : S85 - S88
  • [33] Botulinum toxin treatment in parkinsonism
    Anandan, Charenya
    Jankovic, Joseph
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2024, 456
  • [34] Botulinum toxin for the treatment of depression
    Franca, Katlein
    Lotti, Torello
    DERMATOLOGIC THERAPY, 2017, 30 (02)
  • [35] Botulinum toxin A in the treatment of sialorrhea
    Benson, Jennifer
    Daugherty, Kimberly K.
    ANNALS OF PHARMACOTHERAPY, 2007, 41 (01) : 79 - 85
  • [36] Treatment of Hyperhidrosis With Botulinum Toxin
    Doft, Melissa A.
    Hardy, Krista L.
    Ascherman, Jeffrey A.
    AESTHETIC SURGERY JOURNAL, 2012, 32 (02) : 238 - 244
  • [37] Treatment of wrinkles with botulinum toxin
    Lanzl, I.
    Merte, R.-L.
    OPHTHALMOLOGE, 2007, 104 (09): : 777 - 782
  • [38] TREATMENT OF BLEPHAROSPASM WITH BOTULINUM TOXIN
    PIKIELNY, RT
    MICHELI, FE
    PARDAL, MMF
    PARERA, IC
    GIANNAULA, RJ
    GATTO, M
    MEDICINA-BUENOS AIRES, 1990, 50 (02) : 129 - 134
  • [39] TREATMENT OF SPASTICITY WITH BOTULINUM TOXIN
    BORODIC, GE
    FERRANTE, R
    WIEGNER, AW
    YOUNG, RR
    ANNALS OF NEUROLOGY, 1992, 31 (01) : 113 - 113
  • [40] Botulinum toxin for the treatment of tremor
    Mittal, Shivam Om
    Lenka, Abhishek
    Jankovic, Joseph
    PARKINSONISM & RELATED DISORDERS, 2019, 63 : 31 - 41